Guided Cardiopoiesis Enhances Therapeutic Benefit of Bone Marrow Human Mesenchymal Stem Cells in Chronic Myocardial Infarction

Overview

Journal J Am Coll Cardiol

Specialty Cardiology & Vascular Diseases

Date 2010 Aug 21

PMID 20723802

Citations 117

Authors

Atta Behfar

Satsuki Yamada

Ruben Crespo-Diaz

Jonathan J Nesbitt

Lois A Rowe

Carmen Perez-Terzic

Vinciane Gaussin

Christian Homsy

Jozef Bartunek

Andre Terzic

Affiliations

Soon will be listed here.

Abstract

Objectives: The goal of this study was to guide bone marrow-derived human mesenchymal stem cells (hMSCs) into a cardiac progenitor phenotype and assess therapeutic benefit in chronic myocardial infarction.

Background: Adult stem cells, delivered in their naïve state, demonstrate a limited benefit in patients with ischemic heart disease. Pre-emptive lineage pre-specification may optimize therapeutic outcome.

Methods: hMSC were harvested from a coronary artery disease patient cohort. A recombinant cocktail consisting of transforming growth factor-beta(1), bone morphogenetic protein-4, activin A, retinoic acid, insulin-like growth factor-1, fibroblast growth factor-2, alpha-thrombin, and interleukin-6 was formulated to engage hMSC into cardiopoiesis. Derived hMSC were injected into the myocardium of a nude infarcted murine model and followed over 1 year for functional and structural end points.

Results: Although the majority of patient-derived hMSC in their native state demonstrated limited effect on ejection fraction, stem cells from rare individuals harbored a spontaneous capacity to improve contractile performance. This reparative cytotype was characterized by high expression of homeobox transcription factor Nkx-2.5, T-box transcription factor TBX5, helix-loop-helix transcription factor MESP1, and myocyte enhancer factor MEF2C, markers of cardiopoiesis. Recombinant cardiogenic cocktail guidance secured the cardiopoietic phenotype across the patient cohort. Compared with unguided counterparts, cardiopoietic hMSC delivered into infarcted myocardium achieved superior functional and structural benefit without adverse side effects. Engraftment into murine hearts was associated with increased human-specific nuclear, sarcomeric, and gap junction content along with induction of myocardial cell cycle activity.

Conclusions: Guided cardiopoiesis thus enhances the therapeutic benefit of bone marrow-derived hMSC in chronic ischemic cardiomyopathy.

Citing Articles

Decoded cardiopoietic cell secretome linkage to heart repair biosignature.

Garmany A, Arrell D, Yamada S, Jeon R, Behfar A, Park S Stem Cells Transl Med. 2024; 13(11):1144-1159.

PMID: 39259666 PMC: 11555478. DOI: 10.1093/stcltm/szae067.

Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities.

Zhidu S, Ying T, Rui J, Chao Z Stem Cell Res Ther. 2024; 15(1):266.

PMID: 39183341 PMC: 11346273. DOI: 10.1186/s13287-024-03885-z.

Advancing Myocardial Infarction Treatment: Harnessing Multi-Layered Recellularized Cardiac Patches with Fetal Myocardial Scaffolds and Acellular Amniotic Membrane.

Hassannejad Z, Fendereski K, Daryabari S, Tanourlouee S, Dehnavi M, Kajbafzadeh A Cardiovasc Eng Technol. 2024; 15(6):679-690.

PMID: 39133349 DOI: 10.1007/s13239-024-00744-z.

Bone Marrow and Wharton's Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy.

Tang X, Nasr M, Zheng S, Zoubul T, Stephan J, Uchida S Stem Cell Rev Rep. 2023; 19(7):2429-2446.

PMID: 37500831 PMC: 10579184. DOI: 10.1007/s12015-023-10590-6.

Preclinical Large Animal Porcine Models for Cardiac Regeneration and Its Clinical Translation: Role of hiPSC-Derived Cardiomyocytes.

Sridharan D, Pracha N, Rana S, Ahmed S, Dewani A, Alvi S Cells. 2023; 12(7).

PMID: 37048163 PMC: 10093073. DOI: 10.3390/cells12071090.

References

Arrell D, Niederlander N, Faustino R, Behfar A, Terzic A . Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells. 2007; 26(2):387-400. DOI: 10.1634/stemcells.2007-0599. View

Hahn J, Cho H, Kang H, Kim T, Kim M, Chung J . Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol. 2008; 51(9):933-43. DOI: 10.1016/j.jacc.2007.11.040. View

Ruckdeschel Smith R, Barile L, Cho H, Leppo M, Hare J, Messina E . Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007; 115(7):896-908. DOI: 10.1161/CIRCULATIONAHA.106.655209. View

Wu S, Chien K, Mummery C . Origins and fates of cardiovascular progenitor cells. Cell. 2008; 132(4):537-43. PMC: 2507768. DOI: 10.1016/j.cell.2008.02.002. View

Clavel C, Verfaillie C . Bone-marrow-derived cells and heart repair. Curr Opin Organ Transplant. 2008; 13(1):36-43. DOI: 10.1097/MOT.0b013e3282f428d1. View

Srivastava D, Ivey K . Potential of stem-cell-based therapies for heart disease. Nature. 2006; 441(7097):1097-9. DOI: 10.1038/nature04961. View

Behfar A, Faustino R, Arrell D, Dzeja P, Perez-Terzic C, Terzic A . Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008; 45(4):523-9. PMC: 2586426. DOI: 10.1016/j.yjmcc.2008.09.122. View

Dimmeler S, Leri A . Aging and disease as modifiers of efficacy of cell therapy. Circ Res. 2008; 102(11):1319-30. PMC: 2728476. DOI: 10.1161/CIRCRESAHA.108.175943. View

Bird S, Doevendans P, van Rooijen M, Brutel de la Riviere A, Hassink R, Passier R . The human adult cardiomyocyte phenotype. Cardiovasc Res. 2003; 58(2):423-34. DOI: 10.1016/s0008-6363(03)00253-0. View

10.

Uccelli A, Moretta L, Pistoia V . Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2009; 8(9):726-36. DOI: 10.1038/nri2395. View

11.

Perez-Terzic C, Behfar A, Mery A, van Deursen J, Terzic A, Puceat M . Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res. 2003; 92(4):444-52. DOI: 10.1161/01.RES.0000059415.25070.54. View

12.

Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F . Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95(9):911-21. DOI: 10.1161/01.RES.0000147315.71699.51. View

13.

Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009; 54(24):2277-86. PMC: 3580848. DOI: 10.1016/j.jacc.2009.06.055. View

14.

Quevedo H, Hatzistergos K, Oskouei B, Feigenbaum G, Rodriguez J, Valdes D . Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A. 2009; 106(33):14022-7. PMC: 2729013. DOI: 10.1073/pnas.0903201106. View

15.

Behfar A, Zingman L, Hodgson D, Rauzier J, Kane G, Terzic A . Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 2002; 16(12):1558-66. DOI: 10.1096/fj.02-0072com. View

16.

Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S, Li B . Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410(6829):701-5. DOI: 10.1038/35070587. View

17.

Faustino R, Behfar A, Perez-Terzic C, Terzic A . Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008; 9(1):R6. PMC: 2395240. DOI: 10.1186/gb-2008-9-1-r6. View

18.

Olson E, Schneider M . Sizing up the heart: development redux in disease. Genes Dev. 2003; 17(16):1937-56. DOI: 10.1101/gad.1110103. View

19.

Jiang Y, Jahagirdar B, Reinhardt R, Schwartz R, Keene C, Ortiz-Gonzalez X . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893):41-9. DOI: 10.1038/nature00870. View

20.

Bruneau B, Nemer G, Schmitt J, Charron F, Robitaille L, Caron S . A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 2001; 106(6):709-21. DOI: 10.1016/s0092-8674(01)00493-7. View